Reports for SIVEM PHARMACEUTICALS ULC
Company Name
SIVEM PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
378 |
|
| Actual shortage: | 25 (7%) | |
| Anticipated shortage: | 6 (2%) | |
| Avoided shortage: | 14 (4%) | |
| Resolved: | 333 (88%) | |
Discontinuation Reports |
107 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 100 (93%) | |
| Reversed: | 7 (7%) | |
Late reports |
83 (17%) |
|
Overdue reports |
6 (19%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FLUOXETINE | 20MG | CAPSULE | Resolved | 2017-07-19 | 2017-11-05 | 16495 |
| FLUOXETINE | 20MG | CAPSULE | Avoided shortage | 2018-04-02 | 2018-04-23 | 44590 |
| FLUOXETINE | 20MG | CAPSULE | Resolved | 2018-09-12 | 2019-01-19 | 61375 |
| FLUOXETINE | 20MG | CAPSULE | Resolved | 2018-12-10 | 2019-01-19 | 69054 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2017-07-19 | 2018-04-30 | 16498 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2017-07-19 | 2018-04-30 | 16501 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-11-06 | 2018-04-30 | 28134 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-11-06 | 2018-04-30 | 28137 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-07-19 | 2017-08-10 | 16504 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-07-19 | 2018-04-30 | 16507 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-11-06 | 2018-04-30 | 28140 |
| GABAPENTIN | 600MG | TABLET | Resolved | 2018-05-28 | 2018-07-31 | 50535 |
| GABAPENTIN | 600MG | TABLET | Resolved | 2018-12-17 | 2019-05-13 | 69781 |
| GABAPENTIN | 800MG | TABLET | Resolved | 2018-05-28 | 2018-07-31 | 50538 |
| GABAPENTIN | 800MG | TABLET | Resolved | 2019-01-14 | 2019-04-30 | 72156 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2018-11-12 | 2018-12-21 | 66689 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2018-12-21 | 2019-02-22 | 70366 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2019-04-01 | 2019-07-06 | 80246 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126591 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2023-11-22 | 2024-04-01 | 211146 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53318 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53321 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53324 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53327 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-06-29 | 2018-10-22 | 53330 |
| ATORVASTATIN-10 | 10MG | TABLET | Discontinued | 2019-01-03 | 2019-05-31 | 70938 |
| ATORVASTATIN-20 | 20MG | TABLET | Discontinued | 2019-01-03 | 2019-06-10 | 70941 |
| ATORVASTATIN-40 | 40MG | TABLET | Discontinued | 2019-01-03 | 2019-07-12 | 70944 |
| ATORVASTATIN-80 | 80MG | TABLET | Discontinued | 2017-06-06 | 2017-06-07 | 12012 |
| ATORVASTATIN-80 | 80MG | TABLET | Discontinued | 2019-01-03 | 2019-05-22 | 70947 |
| BICALUTAMIDE | 50MG | TABLET | Discontinued | 2019-06-12 | 2019-11-30 | 86431 |
| BICALUTAMIDE | 50MG | TABLET | Discontinued | 2019-06-12 | 2020-02-21 | 86436 |
| CANDESARTAN | 4MG | TABLET | Discontinued | 2017-06-06 | 2017-06-07 | 12033 |
| CLONAZEPAM | 0.25MG | TABLET | Discontinued | 2017-11-06 | 2017-11-06 | 28145 |
| CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2017-11-06 | 2017-11-06 | 28148 |
| CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2017-11-06 | 2017-11-06 | 28151 |
| CLONAZEPAM | 1MG | TABLET | Discontinued | 2017-11-06 | 2017-11-06 | 28154 |
| CLONAZEPAM | 1MG | TABLET | Discontinued | 2017-11-06 | 2017-12-12 | 28157 |
| CLONAZEPAM | 2MG | TABLET | Discontinued | 2017-11-06 | 2017-11-06 | 28160 |
| CLONAZEPAM | 2MG | TABLET | Discontinued | 2017-11-06 | 2017-12-12 | 28163 |